Acadian Asset Management
ATYR

Acadian Asset Management’s aTyr Pharma ATYR Stock Holding History

Acadian Asset Management’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,366
Closed -$87K – 1920
2024
Q1 		$87K Buy
45,366
+24,704
+120% +$43.1K ﹤0.01% 1312
2023
Q4 		$29K Buy
+20,662
New +$26.5K ﹤0.01% 1542
2023
Q1 		– Sell
-26,419
Closed -$57K – 2006
2022
Q4 		$57K Buy
+26,419
New +$62.3K ﹤0.01% 1558
2022
Q3 		– Sell
-19,963
Closed -$57K – 1882
2022
Q2 		$57K Buy
+19,963
New +$72.2K ﹤0.01% 1477
2021
Q3 		– Sell
-42,724
Closed -$208K – 2062
2021
Q2 		$208K Sell
42,724
-59,973
-58% -$255K ﹤0.01% 1432
2021
Q1 		$457K Buy
102,697
+19,645
+24% +$92.4K ﹤0.01% 1231
2020
Q4 		$322K Hold
83,052
– – ﹤0.01% 1376
2020
Q3 		$269K Buy
83,052
+15,088
+22% +$62K ﹤0.01% 1350
2020
Q2 		$302K Buy
+67,964
New +$247K ﹤0.01% 1354
2019
Q4 		– Sell
-30,576
Closed -$107K – 2092
2019
Q3 		$107K Buy
+30,576
New +$113K ﹤0.01% 1473
2019
Q2 		– Sell
-8,704
Closed -$67K – 2069
2019
Q1 		$67K Hold
8,704
– – ﹤0.01% 1611
2018
Q4 		$60K Hold
8,704
– – ﹤0.01% 1389
2018
Q3 		$99K Buy
8,704
+4,565
+110% +$50K ﹤0.01% 1207
2018
Q2 		$52K Buy
4,139
+1,746
+73% +$41.4K ﹤0.01% 1379
2018
Q1 		$88K Buy
2,393
+1,972
+468% +$92.4K ﹤0.01% 1250
2017
Q4 		$21K Buy
+421
New +$25.9K ﹤0.01% 1361
2017
Q3 		– Sell
-452
Closed -$21K – 1552
2017
Q2 		$21K Buy
452
+86
+23% +$4.03K ﹤0.01% 1253
2017
Q1 		$18K Hold
366
– – ﹤0.01% 1389
2016
Q4 		$11K Hold
366
– – ﹤0.01% 1426
2016
Q3 		$16K Buy
366
+262
+252% +$11.3K ﹤0.01% 1177
2016
Q2 		$4K Buy
+104
New +$4.83K ﹤0.01% 1325
2015
Q4 		– Sell
-12
Closed -$2K – 1524
2015
Q3 		$2K Buy
+12
New +$2.73K ﹤0.01% 1262

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management's ATYR Position: Q2 2024 in Review

Acadian Asset Management sold out of aTyr Pharma (ATYR) in Q2 2024, closing a stake of 45,366 shares — an estimated $87K sold.

Acadian Asset Management first reported a position in ATYR in Q3 2015 and held it in 22 quarters. The position peaked at $457K in Q1 2021. 47 funds tracked by Wall St. Rank hold ATYR as of Q2 2024.

  • Acadian Asset Management reported no remaining aTyr Pharma position as of Q2 2024 after selling out during the quarter.
  • Acadian Asset Management sold 45,366 aTyr Pharma shares in Q2 2024, an estimated $87K.
  • Acadian Asset Management first reported a position in aTyr Pharma in Q3 2015 and held it in 22 quarters.
  • Acadian Asset Management's aTyr Pharma position peaked at $457K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2024.

Based on Acadian Asset Management's 13F filing for Q2 2024, filed 6 Aug 2024.